Interaction of tumor cells and lymphatic vessels in cancer progression.
about
The orphan adhesion G protein-coupled receptor GPR97 regulates migration of lymphatic endothelial cells via the small GTPases RhoA and Cdc42Tumour progression and metastasisLymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-AnalysisOverview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial FluidLymphangiogenesis and metastasis--a closer look at the neuropilin/semaphorin3 axisMouse models for studying angiogenesis and lymphangiogenesis in cancerA transgenic Prox1-Cre-tdTomato reporter mouse for lymphatic vessel researchChronic stress in mice remodels lymph vasculature to promote tumour cell dissemination.Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast CancerCrosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironmentHydrogels to model 3D in vitro microenvironment of tumor vascularizationMicroenvironmental regulation of tumor progression and metastasisMacrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.Tumor microenvironment complexity: emerging roles in cancer therapy.RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth and induces apoptosis in mouse breast cancer in vitro and in vivo.The Fate of the Tumor in the Hands of Microenvironment: Role of TAMs and mTOR Pathway.TIE-2 expressing monocytes in human cancers.Systemic inflammation promotes lung metastasis via E-selectin upregulation in mouse breast cancer model.Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by FluorescenceLymphangiogenesis in Oral Squamous Cell Carcinoma: Correlation with VEGF-C Expression and Lymph Node Metastasis.Mutation of threonine 34 in mouse podoplanin-Fc reduces CLEC-2 binding and toxicity in vivo while retaining antilymphangiogenic activity.Bone marrow-derived cells are implicated as a source of lymphatic endothelial progenitors in human breast cancer.Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathwayBone marrow-derived mesenchymal stem cells drive lymphangiogenesis.Stromal myofibroblasts in potentially malignant and malignant lesions of the oral cavity.Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis.Effects of adenosine on lymphangiogenesisLigand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasisThe landscape of metastatic progression patterns across major human cancersCirculating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumoursA small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.A Comprehensive MicroRNA Expression Profile Related to Hypoxia Adaptation in the Tibetan PigPrimary Tumor-Secreted Lymphangiogenic Factors Induce Pre-Metastatic Lymphvascular Niche Formation at Sentinel Lymph Nodes in Oral Squamous Cell Carcinoma.Role of hypoxia-inducible factor-1α, carbonic anhydrase-IX, glucose transporter-1 and vascular endothelial growth factor associated with lymph node metastasis and recurrence in patients with locally advanced cervical cancerQuantification of regenerative potential in primary human mammary epithelial cells.Lymphangiogenesis in breast cancer is associated with non-sentinel lymph node metastases in sentinel node positive patients.Multifunctional MRI/PET Nanobeacons Derived from the in Situ Self-Assembly of Translational Polymers and Clinical Cargo through Coalescent Intermolecular ForcesRASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma.Direct visualization of changes of lymphatic function and drainage pathways in lymph node metastasis of B16F10 melanoma using near-infrared fluorescence imaging.Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway.
P2860
Q24338992-D8EB34D6-3100-4589-A456-59B9C40300BBQ26766468-29E0EF02-97AB-4071-B6E2-59D5A638697EQ26797490-99EA4719-6533-4021-BCA8-C6CDCF5A76B6Q26799981-FBB0F308-BD23-41C3-8236-1463381F91ADQ26825144-C31ACFB6-DF3A-4E8F-A08B-6552CF4024FDQ27003898-A9216D16-5AAA-41D2-9269-5EA50D706F58Q27310090-9CEF449E-1A0E-4FC6-836F-743900C72EC3Q27333172-4F3A093E-7743-440B-A84D-EE485ACC7F36Q28072448-D772524D-8C27-4954-9E41-AE77FA5B5F1FQ28081431-2E346C75-C810-4EFB-9E8A-72B55A7395C2Q28383786-EA6CD121-B7D0-452E-AA9D-7FCBC0250BADQ29615504-DE710C77-D5CE-45A3-B342-539ABCDC8F06Q30278005-FCB062D1-B88E-4AC5-B3DC-377CA7C3B7DFQ30419311-7901B47A-5472-42B9-B1A5-FDA551D07ADDQ32184965-500EB693-4B06-476C-A14E-8556BA5BB0EDQ33364555-D6C0B503-B6EA-46A7-ADDA-9DC7E1420D46Q33632109-8A96F72E-E863-4238-A808-589CF8CDED11Q33727882-9DFEEBFF-3050-4B38-BE0D-BBBC82887035Q33759991-BF374428-9DA7-480F-9C9F-BA7EAC0AB4ABQ33819978-7A3C85AA-0C34-4DDD-9AF2-5EECD568AC05Q33947226-BDAB45AA-53BD-451B-A6A0-E05F3FE9144AQ34000280-DCBAD1D9-0BDF-47E8-AF99-7ACFCFCE3ED4Q34003819-A25B4416-2458-454E-B324-8021521D000DQ34183523-A4E453DE-49B9-4551-B23F-FB33EC06D530Q34993723-50132E56-B427-41C8-A633-0A3AAAD2413BQ35074335-140D3D22-0279-484C-94D8-98527AD2FEC8Q35126710-690D3F2A-4483-44FF-945D-407E50FDCF60Q35134617-2D6513A2-406A-455A-B0B4-6F95599CA3BDQ35238521-88F180C8-61E4-4CDD-A305-1F0BFF48553EQ35274974-F59FCE80-89C6-4F38-96C3-AA6C4A9B3B51Q35695806-1890D549-CDC1-45F4-9259-5DBD0F600008Q35842087-C6BCBE0F-6CEE-46B9-B938-54AC4A2B145EQ35859226-9900D383-A77E-4C10-A17E-8789BB0C4E16Q36085682-45422F59-8AC1-470C-BC41-65CF13C7E49CQ36091073-434F8528-45D6-4802-AFD9-606095FEDFDBQ36261683-A51BED14-C58B-4646-A230-55616721A0E0Q36436501-C3137055-9F18-492F-8974-ABB4F5425B68Q36544139-52C260B0-EAFB-4A6F-94F4-D08050CC5726Q36911007-C1E92967-2AE4-4063-9A8D-BD22EF2C8143Q36941258-85506BBF-B1D8-452B-93CC-681EB9A131E8
P2860
Interaction of tumor cells and lymphatic vessels in cancer progression.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Interaction of tumor cells and lymphatic vessels in cancer progression.
@en
Interaction of tumor cells and lymphatic vessels in cancer progression.
@nl
type
label
Interaction of tumor cells and lymphatic vessels in cancer progression.
@en
Interaction of tumor cells and lymphatic vessels in cancer progression.
@nl
prefLabel
Interaction of tumor cells and lymphatic vessels in cancer progression.
@en
Interaction of tumor cells and lymphatic vessels in cancer progression.
@nl
P2860
P356
P1433
P1476
Interaction of tumor cells and lymphatic vessels in cancer progression.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2011.602
P407
P577
2011-12-19T00:00:00Z
P5875
P6179
1012731438